Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)
China · Delayed Price · Currency is CNY 18.29
-0.29 (-1.56%)
Sep 23, 2026, 3:00 PM CST
SHA:688639 Market Cap
SHA:688639 has a market cap or net worth of 4.56 billion as of September 23, 2026. Its market cap has decreased by -44.69% in one year.
Market Cap
4.56B
Enterprise Value
6.49B
Revenue
3.00B
Ranking
n/a
PE Ratio
38.78
Stock Price
18.29
ChartMarket Cap Chart
Since April 22, 2021, SHA:688639's market cap has increased from 3.81B to 4.56B, an increase of 19.82%. That is a compound annual growth rate of 3.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 4.56B | -43.86% |
| Dec 31, 2025 | 8.13B | 10.70% |
| Dec 31, 2024 | 7.34B | -62.99% |
| Dec 29, 2023 | 19.83B | 17.86% |
| Dec 30, 2022 | 16.83B | 20.56% |
| Dec 31, 2021 | 13.96B | 266.67% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ChemPartner PharmaTech | 5.04B |
| Kexing Biopharm | 5.00B |
| Shanghai Obio Technology (Group) Corp. | 4.94B |
| Shenzhen Weiguang Biological Products | 4.94B |
| Beijing Konruns Pharmaceutical | 4.70B |
| Zhejiang Wecome Pharmaceutical Company | 4.41B |
| Wuhan Hvsen Biotechnology | 4.35B |
| Xiangxue Pharmaceutical | 4.34B |